← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
St Jude Children'S Research Hospital Inc
$16,546,328
Total funding
16
Grants
Funding over time
peak $5.7M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$16,546,328 · 16
By mechanism
—$16,546,328 · 16
Investigators at St Jude Children'S Research Hospital Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
HEARING RESTORATION IN MOUSE MODELS WITH NOISE-INDUCED HEARING LOSS$4,752,467
· FY2009 · Department of Defense
PRE-MRNA SPLICING AS A THERAPEUTIC VULNERABILITY OF PEDIATRIC LIVER CANCER$1,679,104
· FY2025 · Defense Health Agency
THERAPEUTICS FOR REGENERATION OF FULLY FUNCTIONAL AUDITORY OUTER HAIR CELLS$1,324,200
· FY2012 · Department of Defense
CREATING CURES FOR PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS$1,295,000
· FY2024 · Defense Health Agency
CONQUER: CAR T-CELL LONG-TERM FOLLOW-UP, QUALITY OF LIFE, AND ADVERSE REACTIONS$1,294,957
· FY2025 · Defense Health Agency
IDENTIFICATION OF NEK5 AS A HIDDEN DRIVER IN KIDNEY CANCER$1,036,000
· FY2025 · Defense Health Agency
CELL INTRINSIC AND EXTRINSIC MODIFIERS OF BMF PROGRESSION IN SAMD9L SYNDROMES$980,501
· FY2025 · Defense Health Agency
XPO1 AS A THERAPEUTIC TARGET IN ZFTA-RELA-DRIVEN EPENDYMOMA$724,918
· FY2025 · Defense Health Agency
THE DEVELOPMENT OF A PRIMARYNEURAL CREST ASSAY FOR NEUROBLASTOMA ONCOGENESIS$630,000
· FY2014 · Department of Defense
SMARCAL1: A UNIQUE TARGET IN ALT-POSITIVE PEDIATRIC SOLID TUMORS$591,248
· FY2024 · Defense Health Agency
TUMOR GROWTH MODEL WITH PK INPUT FOR NEUROBLASTOMA DRUG$521,460
· FY2014 · Department of Defense
MOLECULAR-TARGETED THERAPIES OF CHILDHOOD CHOROID PLEXUS CARCINOMA$517,032
· FY2010 · Department of the Army
MOLECULAR-TARGETED THERAPIES OF CHILDHOOD CHROID PLEXUS CARCINOMA$505,703
· FY2010 · Department of the Army
MOLECULAR-TARGETED THERAPIES OF CHILDHOOD CHOROID PLEXUS CARCINOMA$358,150
· FY2010 · Department of the Army
NOVEL TRANSCRIPTION FACTORS FOR REGENERATION OF FUNCTIONAL OUTER HAIR CELLS AFTER NOISE INJURY$221,948
· FY2016 · Department of the Navy
NOVEL SMALL MOLECULE ANTAGONISTS OF THE INTERACTION OF THE ANDROGEN RECEPTOR AND TRANSCRIPTIONAL CO-REGULATORS$113,640
· FY2008 · Department of Defense